Showing results (31-40 of 279) with videos related to
Sort By:
Pageof 28
Antimicrobial Agents and Chemotherapy|February 1, 1995
Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacinJ Child, J M Andrews, R WiseAntimicrobial Agents and Chemotherapy|August 1, 1986
In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agentsN Manek, J M Andrews, R WiseAntimicrobial Agents and Chemotherapy|December 1, 1984
In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agentsR Wise, C Cross, J M AndrewsThe Journal of Antimicrobial Chemotherapy|January 1, 1993
The in-vitro activity of Bay y 3118, a new chlorofluoroquinoloneR Wise, J M Andrews, N BrenwaldAntimicrobial Agents and Chemotherapy|December 1, 1983
Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibioticsR Wise, J M Andrews, G DanksThe Journal of Antimicrobial Chemotherapy|August 1, 1991
The in-vitro activity of cefdinir (FK482), a new oral cephalosporinR Wise, J M Andrews, D ThornberAntimicrobial Agents and Chemotherapy|May 1, 1996
In vitro activity of the tricyclic beta-lactam GV104326R Wise, J M Andrews, N BrenwaldThe Journal of Antimicrobial Chemotherapy|June 1, 1992
In-vitro activity of tosufloxacin, a new quinolone antibacterial agentM A Cooper, J M Andrews, R WiseThe Journal of General Virology|January 8, 1999
The effect of the cellular stress response on human T-lymphotropic virus type I envelope protein expressionJ M Andrews, M Oglesbee, M D LairmoreThe Journal of Antimicrobial Chemotherapy|May 1, 1992
In-vitro activity of PD 131628, a new quinolone antimicrobial agentM A Cooper, J M Andrews, R WisePageof 28